|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-3-30
|
|
pubmed:abstractText |
Chronic idiopathic urticaria (CIU) is the most common type of chronic urticaria, and pruritus is the most prominent symptom. Antihistamines are the first-line treatment for CIU. Sedation and anticholinergic adverse effects are often experienced with the first-generation antihistamines and there is a risk of cardiovascular adverse effects and drug interactions with some second-generation agents. Hence, new treatment options are needed. Desloratadine is a new, potent, nonsedating antihistamine that has an excellent cardiovascular safety profile.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0011-9059
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
40
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
72-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11277962-Adolescent,
pubmed-meshheading:11277962-Adult,
pubmed-meshheading:11277962-Aged,
pubmed-meshheading:11277962-Cholinergic Antagonists,
pubmed-meshheading:11277962-Chronic Disease,
pubmed-meshheading:11277962-Dizziness,
pubmed-meshheading:11277962-Double-Blind Method,
pubmed-meshheading:11277962-Drug Administration Schedule,
pubmed-meshheading:11277962-Fatigue,
pubmed-meshheading:11277962-Female,
pubmed-meshheading:11277962-Headache,
pubmed-meshheading:11277962-Humans,
pubmed-meshheading:11277962-Loratadine,
pubmed-meshheading:11277962-Male,
pubmed-meshheading:11277962-Middle Aged,
pubmed-meshheading:11277962-Pharyngitis,
pubmed-meshheading:11277962-Pruritus,
pubmed-meshheading:11277962-Respiratory Tract Infections,
pubmed-meshheading:11277962-Treatment Outcome,
pubmed-meshheading:11277962-Urticaria,
pubmed-meshheading:11277962-Virus Diseases
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Once-daily desloratadine improves the signs and symptoms of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study.
|
|
pubmed:affiliation |
Klinik und Poliklinik fur Dermatologie und Allergologie am Biederstein, Technische Universität München, München, Germany.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
